** Shares of pathogen elimination technology company Molekule Group down 7.9% at $1.64
** Company reports Q2 loss of 76 cents per share vs 37 cents per share loss a year ago
** MKUL sees revenue for second half of 2023 at $28.5 mln-$33.5 mln
** Shares down ~50% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))